SCHEMBL30015366

SCHEMBL30015366

COC(=O)C=Cc1ccc(-c2ccc(OCC(=O)O)c(C34CC5CC(CC(C5)C3)C4)c2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC11 Q96DB2 5/20 0.74
HDAC2 Q92769 2/20 0.64
HDAC7 Q8WUI4 2/20 0.60
HDAC8 Q9BY41 2/20 0.60
HDAC6 Q9UBN7 2/20 0.60
HDAC1 Q13547 1/20 0.60
RARB P10826 6/20 0.54
HDAC3 O15379 1/20 0.53
HDAC4 P56524 1/20 0.53
HDAC9 Q9UKV0 1/20 0.53
HDAC5 Q9UQL6 1/20 0.53
RARA P10276 4/20 0.51
IKBKB O14920 1/20 0.51
RARG P13631 3/20 0.47
MEN1 O00255 1/20 0.47
NR1I2 O75469 1/20 0.47
LMNA P02545 1/20 0.47
PGR P06401 1/20 0.47
HSPD1 P10809 1/20 0.47
GOT1 P17174 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30015930 0.90 HDAC11 (0.83) HDAC11HDAC2HDAC7HDAC8HDAC6
SCHEMBL22929243 0.90 HDAC11 (0.83) HDAC11HDAC2HDAC7HDAC8HDAC6
SCHEMBL29462780 0.90 HDAC11 (0.65) HDAC11HDAC2HDAC7HDAC8HDAC6
SCHEMBL30015801 0.90 HDAC11 (0.73) HDAC11HDAC2HDAC7HDAC8HDAC6
SCHEMBL30016167 0.88 HDAC11 (0.66) HDAC11HDAC2HDAC7HDAC8HDAC6
SCHEMBL30016430 0.88 HDAC11 (0.66) HDAC11HDAC2HDAC7HDAC8HDAC6
SCHEMBL405445 0.88 HDAC11 (0.82) HDAC11HDAC2HDAC7HDAC8HDAC6
SCHEMBL405444 0.88 HDAC11 (0.82) HDAC11HDAC2HDAC7HDAC8HDAC6
SCHEMBL15232880 0.87 HDAC11 (0.64) HDAC11HDAC2HDAC7HDAC8HDAC6
SCHEMBL2416033 0.87 HDAC11 (0.64) HDAC11HDAC2HDAC7HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110114338-B Retinoid derivatives having antitumor activity 比奥吉公司 2022-10-21 CN disclosed